nodes	percent_of_prediction	percent_of_DWPC	metapath
Pheniramine—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.167	0.19	CbGpPWpGaD
Pheniramine—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0453	0.0518	CbGpPWpGaD
Pheniramine—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0444	0.0507	CbGpPWpGaD
Pheniramine—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0381	0.0435	CbGpPWpGaD
Pheniramine—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0373	0.0426	CbGpPWpGaD
Pheniramine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0269	0.0307	CbGpPWpGaD
Pheniramine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0259	0.0296	CbGpPWpGaD
Pheniramine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.025	0.0286	CbGpPWpGaD
Pheniramine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0242	0.0277	CbGpPWpGaD
Pheniramine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0238	0.0272	CbGpPWpGaD
Pheniramine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0235	0.0269	CbGpPWpGaD
Pheniramine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0226	0.0258	CbGpPWpGaD
Pheniramine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.0219	0.025	CbGpPWpGaD
Pheniramine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.021	0.024	CbGpPWpGaD
Pheniramine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0204	0.0233	CbGpPWpGaD
Pheniramine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.02	0.0229	CbGpPWpGaD
Pheniramine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.0198	0.0226	CbGpPWpGaD
Pheniramine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0184	0.021	CbGpPWpGaD
Pheniramine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0153	0.0175	CbGpPWpGaD
Pheniramine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0129	0.0147	CbGpPWpGaD
Pheniramine—Captodiame—DRD3—attention deficit hyperactivity disorder	0.0112	0.0904	CrCbGaD
Pheniramine—Phenoxybenzamine—ADRA2C—attention deficit hyperactivity disorder	0.00876	0.0705	CrCbGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00875	0.00999	CbGpPWpGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00857	0.00979	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00851	0.00972	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0075	0.00856	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00734	0.00839	CbGpPWpGaD
Pheniramine—Doxepin—ADRA2C—attention deficit hyperactivity disorder	0.00713	0.0573	CrCbGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00594	0.00678	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00571	0.00652	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00559	0.00639	CbGpPWpGaD
Pheniramine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00548	0.00626	CbGpPWpGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00519	0.00593	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00509	0.00581	CbGpPWpGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00483	0.00551	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00481	0.00549	CbGpPWpGaD
Pheniramine—Chlorphenamine—SLC6A3—attention deficit hyperactivity disorder	0.00471	0.0379	CrCbGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00468	0.00534	CbGpPWpGaD
Pheniramine—Modafinil—SLC6A3—attention deficit hyperactivity disorder	0.0046	0.037	CrCbGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0046	0.00525	CbGpPWpGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00454	0.00518	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00445	0.00508	CbGpPWpGaD
Pheniramine—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.00438	0.0352	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00437	0.00499	CbGpPWpGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00423	0.00483	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00414	0.00472	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00401	0.00457	CbGpPWpGaD
Pheniramine—Benzphetamine—SLC6A3—attention deficit hyperactivity disorder	0.00399	0.0321	CrCbGaD
Pheniramine—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.00396	0.0318	CrCbGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00394	0.0045	CbGpPWpGaD
Pheniramine—Benzphetamine—ADRA2A—attention deficit hyperactivity disorder	0.00391	0.0315	CrCbGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00389	0.00444	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00388	0.00443	CbGpPWpGaD
Pheniramine—Cyclobenzaprine—HTR2A—attention deficit hyperactivity disorder	0.00387	0.0311	CrCbGaD
Pheniramine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00383	0.00438	CbGpPWpGaD
Pheniramine—Phenoxybenzamine—ADRA2A—attention deficit hyperactivity disorder	0.00374	0.0301	CrCbGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00362	0.00414	CbGpPWpGaD
Pheniramine—Chlorphenamine—SLC6A4—attention deficit hyperactivity disorder	0.00352	0.0283	CrCbGaD
Pheniramine—Promazine—DRD4—attention deficit hyperactivity disorder	0.00344	0.0276	CrCbGaD
Pheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00343	0.00391	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00339	0.00387	CbGpPWpGaD
Pheniramine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.00325	0.0262	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00323	0.00368	CbGpPWpGaD
Pheniramine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.00319	0.0257	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00316	0.00361	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00315	0.0036	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00305	0.00348	CbGpPWpGaD
Pheniramine—Doxepin—ADRA2A—attention deficit hyperactivity disorder	0.00304	0.0245	CrCbGaD
Pheniramine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.003	0.00342	CbGpPWpGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00296	0.00338	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00296	0.00338	CbGpPWpGaD
Pheniramine—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.00296	0.0238	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00293	0.00335	CbGpPWpGaD
Pheniramine—Promazine—DRD1—attention deficit hyperactivity disorder	0.00291	0.0234	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00287	0.00328	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00276	0.00315	CbGpPWpGaD
Pheniramine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.0027	0.0217	CrCbGaD
Pheniramine—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	0.00266	0.0214	CrCbGaD
Pheniramine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00258	0.00295	CbGpPWpGaD
Pheniramine—Amitriptyline—DRD3—attention deficit hyperactivity disorder	0.00258	0.0207	CrCbGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00254	0.0029	CbGpPWpGaD
Pheniramine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	0.00243	0.0196	CrCbGaD
Pheniramine—Trimipramine—DRD2—attention deficit hyperactivity disorder	0.00242	0.0195	CrCbGaD
Pheniramine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	0.00241	0.0194	CrCbGaD
Pheniramine—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	0.00235	0.0189	CrCbGaD
Pheniramine—Doxepin—SLC6A4—attention deficit hyperactivity disorder	0.00232	0.0187	CrCbGaD
Pheniramine—Doxepin—DRD2—attention deficit hyperactivity disorder	0.00231	0.0186	CrCbGaD
Pheniramine—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	0.00227	0.0183	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00219	0.0025	CbGpPWpGaD
Pheniramine—Promazine—DRD2—attention deficit hyperactivity disorder	0.00205	0.0165	CrCbGaD
Pheniramine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00201	0.0023	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00199	0.00227	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00193	0.00221	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00191	0.00219	CbGpPWpGaD
Pheniramine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	0.00187	0.015	CrCbGaD
Pheniramine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	0.0018	0.0145	CrCbGaD
Pheniramine—Imipramine—DRD2—attention deficit hyperactivity disorder	0.0018	0.0144	CrCbGaD
Pheniramine—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	0.00179	0.0144	CrCbGaD
Pheniramine—Amitriptyline—DRD2—attention deficit hyperactivity disorder	0.00178	0.0144	CrCbGaD
Pheniramine—Doxepin—HTR2A—attention deficit hyperactivity disorder	0.00178	0.0143	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00178	0.00203	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00174	0.00199	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00173	0.00198	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00172	0.00197	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.0017	0.00194	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00169	0.00194	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00167	0.00191	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00166	0.0019	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00162	0.00185	CbGpPWpGaD
Pheniramine—Promazine—HTR2A—attention deficit hyperactivity disorder	0.00158	0.0127	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00157	0.00179	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00156	0.00178	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00154	0.00176	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00152	0.00174	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00142	0.00162	CbGpPWpGaD
Pheniramine—Imipramine—HTR2A—attention deficit hyperactivity disorder	0.00139	0.0112	CrCbGaD
Pheniramine—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	0.00138	0.0111	CrCbGaD
Pheniramine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00118	0.00134	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00109	0.00125	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00103	0.00117	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000992	0.00113	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000955	0.00109	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000925	0.00106	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000909	0.00104	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000898	0.00103	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000836	0.000955	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000586	0.000669	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.00031	0.000354	CbGpPWpGaD
